About
Profile
Headquarters
Intraday
High
-
Low
-
52-week
High
-
Low
-
QGEN
...
Available for logged in users only.
The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.
Contact us via Twitter if you are interested in trying it out.
- Qiagen Non-GAAP EPS of $0.50 beats by $0.02, revenue of $470M misses by $0.85M
- Qiagen Q3 2023 Earnings Preview
- U.S. govt. to restart program to ship free at-home COVID tests
- AI to represent 11% of healthcare budgets in 2024 - Morgan Stanley
- Qiagen Non-GAAP EPS of $0.51 beats by $0.01, revenue of $497M beats by $4.02M
- Qiagen gets FDA approval for Ayvakit companion diagnostic test
- Qiagen Q2 2023 Earnings Preview
- QIAGEN says FBI approved workflow solution for the national database
- Qiagen Non-GAAP EPS of $0.51 beats by $0.05, revenue of $485M beats by $6.77M
- Qiagen Q1 2023 Earnings Preview
- Biden signs bill to end COVID national emergency
- Democratic senators urge U.S. to maintain free COVID tests under Medicare
- Qiagen to develop companion diagnostic test for Servier's blood cancer drug Tibsovo
- Qiagen, SOPHiA team up for next-generation sequencing
- Qiagen 2023 sales, EPS guidance close to consensus estimates
- Qiagen Non-GAAP EPS of $0.53, revenue of $498M, FY23 guidance initiated
- Qiagen Q4 2022 Earnings Preview
- Pre-event M&A has busy week in store with several earnings scheduled
- Qiagen to consider selling stake in $1B bioinformatics division - report
- Qiagen acquires Verogen for $150M to bolster forensics portfolio